W Health Ventures(W Health Ventures)为在印度和美国启动8 - 10个保健新企业的第二个基金关闭了60M元, 重点是肿瘤学、长寿和AI。 W Health Ventures closed $60M for its second fund to launch 8–10 healthcare startups in India and the U.S., focusing on oncology, longevity, and AI.

W Health Ventures已经达到其第二个基金的首个尾端,筹集了550亿克鲁塞罗(6 000万美元),目标是630亿克鲁塞罗,目的是在今后四年内启动8-10个新的保健新开办企业。 W Health Ventures has reached the first close of its second fund, raising ₹550 crore ($60 million) with a target of ₹630 crore, aiming to launch 8-10 new healthcare startups over the next four years. 该公司以印度和美国为基地, 正在翻番, 重心是肿瘤学、长寿、慢性疼痛和AI驱动的解决方案。 The firm, based in India and the U.S., is doubling down on its "found and fund" model, focusing on oncology, longevity, chronic pain, and AI-driven solutions. 三分之二的资本将以印度企业为目标,其余的资本将流向美国的机会。 Two-thirds of capital will target Indian ventures, with the rest going to U.S. opportunities. 基金已经投资到Everhope肿瘤学 并正在孵化一个美国精神病学平台 The fund has already invested in Everhope Oncology and is incubating a U.S. psychiatry platform. 投资者包括来自两国的家庭事务办公室和机构,其中大多数在美国。 Investors include family offices and institutions from both countries, with a majority based in the U.S.